×
COVID-19 and Obsessive-Compulsive Disorder: The Nightmare Just Got Real PDF
$ 40.00
COVID-19 and Obsessive-Compulsive Disorder: The Nightmare Just Got Real PDF quantity
$ 40.00
×
Electroconvulsive Therapy Device Classification: Response to FDA Advisory Panel Hearing and Recommendations PDF
$ 40.00
Electroconvulsive Therapy Device Classification: Response to FDA Advisory Panel Hearing and Recommendations PDF quantity
$ 40.00
×
Suicidal Behavior in Obsessive-Compulsive Disorder PDF
$ 40.00
Suicidal Behavior in Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial PDF
$ 40.00
Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial PDF quantity
$ 40.00
×
Bioavailability of S -Adenosyl Methionine and Impact on Response in a Randomized, Double-Blind, Placebo-Controlled Trial in Major Depressive Disorder PDF
$ 40.00
Bioavailability of S-Adenosyl Methionine and Impact on Response in a Randomized, Double-Blind, Placebo-Controlled Trial in Major Depressive Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart